Is it time to fund routine NHS usage of PSMA PET-CT?-Reference-Cited by-同舟云学术

Is it time to fund routine NHS usage of PSMA PET-CT?

Published:2019-10 Issue:10 Volume:40 Page:975-979
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Afaq Asim,Ell Peter J,Bomanji Jamshed B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference15 articles.

1. Comparison of [68Ga]Ga-PSMA-HBED-CC PET versus whole-body bone scintigraphy for the detection of bone metastases in patients with prostate cancer.;Schreiter;J Nucl Med Radiat Ther,2016

2. Comparison of bone scintigraphy and 68ga-PSMA PET for skeletal staging in prostate cancer.;Pyka;Eur J Nucl Med Mol Imaging,2016

3. 68ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT.;Bluemel;Clin Nucl Med,2016

4. Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit.;Ell;Eur J Nucl Med Mol Imaging,2019

5. 68ga-PSMA PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.;Fendler;Eur J Nucl Med Mol Imaging,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer;Archivio Italiano di Urologia e Andrologia;2022-12-27

2. Using PSMA imaging for prognostication in localized and advanced prostate cancer;Nature Reviews Urology;2022-12-06

3. Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2022-01-24

4. Prostate Cancer Theranostics;PET Clinics;2021-07

5. A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study;Journal of Nuclear Medicine;2021-03-19